Tagged: Zoetis
News (5)
NewsZoetis Q3 companion animal revenue falls 5% to US$1.57 billion as livestock sales rise 7%
The US animal health company narrowed its 2026 revenue guidance and raised its adjusted earnings forecast despite continued pressure in its pet business.
NewsWhy hatchery vaccination is key to protecting flocks early
The final part of Zoetis's Hatchery Health Team series looks at how in ovo and day-of-age vaccination can close the immunity gap in broilers.
NewsZoetis receives FDA approval for Convenia RTU for Dogs, helping more medium and large dogs access single-injection treatment
The more concentrated cefovecin formulation provides up to 14 days of antibiotic treatment for bacterial skin infections in one injection, with launch expected in Q1 2027.
NewsIn Ovo Vaccination Myths Could Be Costing Hatchery Performance
Zoetis' Hatchery Health Team says many of the process breakdowns they investigate at hatcheries worldwide are mistaken for problems with in ovo vaccination itself.
NewsZoetis to acquire animal genomics business from Neogen
Zoetis Inc. announced on March 2 that it has entered into a definitive agreement with Neogen Corporation to acquire Neogen's animal genomics business for $160 million, subject to customary closing adjustments.